Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chenxin Fodu Pharmaceutical Co., Ltd. is a large-scale pharmaceutical manufacturing enterprise based in Jining, China, and serves as a primary production hub for its parent company, Chenxin Pharmaceutical. The company specializes in the development and mass production of a wide array of generic drugs, including large-volume parenterals, small-volume injections, and solid oral dosage forms like tablets and capsules. Its extensive product portfolio primarily addresses therapeutic needs in anti-infectives, fluid and electrolyte management, and cardiovascular health. Operating from modern, GMP-certified facilities in the Wenshang Economic Development Zone, the company utilizes advanced technologies such as Blow-Fill-Seal for its injectable products. As a key player in the regional pharmaceutical industry, it focuses on ensuring the supply of high-quality, affordable essential medicines to the Chinese healthcare market. The company is recognized for its industrial scale and commitment to quality standards within the Chenxin Group's broader operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东辰欣佛都药业.